Testagen

Testes & pituitary Research only Preliminary Synthetic short peptide (Cytogen)

Also called KEDG peptide

A four-amino-acid Khavinson peptide associated with the testes. Animal reports describe effects on the pituitary, including thyroid-stimulating hormone and thyroid hormone levels, and it is promoted for supporting testosterone, although published evidence for that is thin.

Evidence at a glance

Evidence
Preliminary — Very little published work
Status
Research compound only
Dosing
No human study has set a dose

Promoted for testosterone support, but published evidence for that specific claim is thin.

What studies report

How it works

A Khavinson short peptide: at two to four amino acids it is small enough to pass through cell and nuclear membranes intact. The proposed mechanism is that it binds specific sites on nuclear DNA and changes which genes are switched on in its target tissue, rather than acting on a surface receptor the way most peptides do.

Small enough to pass through and act on DNA in the nucleus

Where it acts

Testes

The library groups this compound under Testes & pituitary. The diagram shows that target, not every tissue it reaches.

Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.

Why people take it

Testosterone supportThyroid hormone

Reasons people seek it out — not a list of proven effects.

Status: Limited animal data, mostly from one research group.

Route
Subcutaneous injection, or oral capsule depending on the preparation
Sequence
Lys-Glu-Asp-Gly
Formula
C17H29N5O9
Molecular weight
447.4 g/mol
Available as
20 mg

Search PubMed for Testagen → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.